Inventor

OTT GREGORY R

US25 patents

⚠️ This page may combine multiple inventors who share the name “OTT GREGORY R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OTT GREGORY R

CEPHALON INC

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Macrocyclic compounds as ALK, FAK and JAK2 inhibitors

Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor

Imidazo[4,5-b]pyridine derivatives as ALK and JAK modulators for the treatment of proliferative disorders

Pyrrolotriazines as ALK inhibitors

CANCER RESEARCH TECH LTD

Pyrimidinone derivatives as CDC7 inhibitors

Pyrimidinone derivatives as Cdc7 inhibitors

Thienopyrimidine inhibitors of atypical protein kinase C

Thienopyrimidine inhibitors of atypical protein kinase C

Preparation and uses of pyrimidinone derivatives

Azaquinazoline inhibitors of atypical protein kinase C

AHMED GULZAR

Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors

Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors

IGNYTA INC

Azaquinazoline inhibitors of Atypical protein Kinase C

Azaquinazoline inhibitors of atypical protein kinase C

NXERA PHARMA UK LTD

CGRP antagonist compounds

CGRP antagonist compounds

BRISTOL MYERS SQUIBB CO

Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)

CANCER RES TECH LTD

Thienopyrimidine inhibitors of atypical protein kinase C

BRESLIN HENRY J

Pyrrolotriazines as ALK and JAK2 inhibitors

BRISTOL MYERS SQUIBB PHARMA CO

Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)

BRISTOL MYERS SQUIBB PHARMA

Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)